Contact Us

Defective Medical Devices
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date when device was implanted :

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Medtronic Quick-set Infusion Set

Medtronic Quick-Set Infusion Set Could Result In Overdose Lawsuits

Medtronic Quick-Set Infusion Set | Lawsuits, Lawyers | Side Effects: Overdose, Ketoacidosis, Hyperglycemia | Not Vented Properly, Interference Of Insulin Delivery

Diabetics who rely on Quick-set infusion sets used with Medtronic Inc.'s MiniMed Paradigm insulin pumps need to know that some of these infusion sets may not work.  In July 2009, Medtronic initiated a recall of one lot of Quick-set infusion sets because the devices might not vent properly. This defect could interfere with the infusion set's ability to deliver insulin, leading to serious injury or even death.

Thousands of diabetics use Quick-set infusion sets to help manage their disease.  The malfunction of one of these devices could cause either too much or too little insulin to reach their blood stream. The results of such an event could be catastrophic.  If you or someone you love were injured because of one of these devices, our Medtronic Quick-set infusion set recall lawyers want to hear from you.

Our Medtronic Quick-set infusion set injury lawyers are currently offering free case evaluations to anyone who was injured by one of the faulty insulin infusion sets.  Please contact our office today to protect your legal rights.

Quick-set Infusion Set Recall

Medtronic's Quick-set infusion set is a thin plastic tube used to deliver insulin from the MiniMed Paradigm insulin pump to a diabetes patient. The device is typically replaced by the patient every three days.

In announcing the Quick-set infusion set recall, Medtronic said it had discovered that approximately two percent of Lot 8 Quick-set infusion sets may not allow the insulin pump to vent air pressure properly. This could potentially result in the device delivering too much or too little insulin and may lead to serious injury or death. Patients were told to stop using the Quick-set infusion sets from Lot 8 immediately.

Medtronic said its investigation of the venting problem revealed that a lubricant clogged the vents in some of the affected Quick-set infusion sets. To solve this situation, the lubricant has been eliminated from the manufacturing process.

The Quick-set infusion sets involved in this recall bear reference numbers MMT-396, MMT-397, MMT-398 and MMT-399 with lot numbers starting with the number “8. The lot number (for example 8XXXXXX) is clearly marked on both the product box label, and on each individual infusion set package. Lot 8 Quick-set infusion sets were distributed in the United States, and in limited quantities in a small number of countries outside of the United States. The list of countries affected by this recall is available at or by contacting any Medtronic country office. No other Medtronic devices or infusion sets are involved in this recall.

Customers are being asked to return any affected infusion sets to the company. Medtronic is providing customers with replacement Quick-set infusion sets at no additional charge. Medtronic said it mailed out notification letters to customers, as well as one million replacement sets, which represent a 30-day supply.

Consequences of a Defective Quick-set Infusion Set

A defective Quick-set infusion set could cause a MiniMed Paradigm insulin pump to deliver too much or too little insulin to a diabetic patient.  Insulin is a hormone naturally produced by the pancreas. It enables the body to use the sugar in food as a source of energy. Diabetics do not produce enough insulin, which makes it impossible for their bodies to regulate blood sugar.

If a defective Quick-set infusion set causes the delivery of too much insulin, insulin overdose could occur.   Symptoms of an insulin overdose reflect very low blood sugar levels (hypoglycemia) and include headache, irregular heartbeat, increased heart rate or pulse, sweating, tremor, nausea, increased hunger, and anxiety. In very extreme cases, insulin overdose can cause death.  If you suspect overdose, seek medical attention immediately.

Too little insulin can cause symptoms of high blood sugar (hyperglycemia) which include confusion, drowsiness, rapid breathing, fruity breath odor, increased urination or unusual thirst. If you fail to treat hyperglycemia, a condition called ketoacidosis (diabetic coma) could occur.  Ketoacidosis is life-threatening.

Legal Help for Victims of Faulty Medtronic Quick-Set Infusion Sets

Millions of people rely on Medtronic's Quick-set infusion sets to help manage their diabetes.  Unfortunately, they may have suffered serious injuries if the set they were depending on was part of the Medtronic Quick-set infusion set recall.

Our law firm is currently investigating potential lawsuits against Medtronic on behalf of people injured by defective Quick-set infusion sets.  To discuss your case with one of our Medtronic Quick-set infusion set recall lawyers, please fill out our online form or call 1-800 YOURLAWYER (1-800-968-7529) today.


Medtronic Quick-set Infusion SetRSS Feed

UK Medical Device Alert Issued Over Medtronic Insulin Infusion Pump

May 30, 2014
The Medicines and Healthcare Products Regulatory Agency (MHRA) has recently issued a Medical Device Alert over the Paradigm ambulatory insulin infusion pump manufactured and marketed by Medtronic Inc. The MHRA is a United Kingdom government agency responsible for drug and medical device safety and efficacy. The MHRA is similar to the U.S. Food and Drug Administration (FDA). The recalled Medtronic Paradigm ambulatory insulin infusion pumps include the following models: MMT- 511, 512, 712,...

Class I recall issued for Medtronic SynchroMed infusion pumps

Dec 24, 2012
The Food and Drug Administration has issued a Class I recall on two models of Medtronic SynchroMed drug infusion pumps because defects could cause them to fail to deliver a drug. According to a recall statement from the agency, the recall involves SynchroMed drug infusion pumps manufactured since May 1998 until November 2012. They were distributed from April 1999 until November 2012. The Class I recall indicates that it is the agency's most serious warning. A Class I recall means that use of a...

Medtronic Announces Layoffs, as Infuse Controversies Drag Down Sales

Sep 28, 2012 | Parker Waichman LLP
Medtronic announced in May it would be cutting some 1,000 jobs, as the controversy surrounding its Infuse Bone Graft product continues to weigh on the medical device maker’s bottom line.  "We are eliminating about 1,000 positions around the company and around the globe," Gary Ellis, the company's chief financial officer, told the Minneapolis Star Tribune at the time. "It's kind of the normal, ongoing thing that goes forward as we shift resources from slower-growing markets to ...

Medtronic Unit Settles Defective Spine Device Lawsuit

Apr 29, 2011 | Parker Waichman LLP
A lawsuit involving the Danek 3-D TSRH Spinal System made by a unit of Medtronic Inc.  has been settled, according to a report from Law360.   The lawsuit was brought by a Puerto Rican woman and her family who claimed the Danek 3-D TSRH Spinal System caused her to suffer serious and life threatening injuries.According to Law360, the Danek 3-D TSRH Spinal was recalled by the U.S. Food & Drug Administration (FDA) because of a manufacturing defect that could cause the implant to...

Medtronic Says California Seeking Info on Heart Rhythm Devices

Dec 10, 2009 | Parker Waichman LLP
Medtronic Inc. is being investigated in California over its heart rhythm devices.  According to The Wall Street Journal, Medtronic recently disclosed that it had received a subpoena from the Department of Health and Human Services' Office of Inspector General in California.Medtronic reported the subpoena in a quarterly filing with the Securities and Exchange Commission (SEC) it had made on Wednesday.  The disclosure read as follows:"On September 16, 2009, the Company received a...

More Medtronic Quick-set Infusion Set News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo